Department of Medical Biochemistry, Royal Gwent Hospital, Newport NP20 2UB, UK.
Department of Medical Biochemistry, Immunology and Toxicology, University Hospital of Wales, Cardiff CF14 4XW, UK.
J Clin Endocrinol Metab. 2024 Jan 18;109(2):e579-e588. doi: 10.1210/clinem/dgad576.
The serum total cortisol response to the ACTH stimulation test is widely used to assess adrenocortical function but is affected by changes in cortisol-binding globulin (CBG) concentration. Salivary cortisol reflects free cortisol concentrations and may offer a reliable alternative.
(1) To establish the salivary cortisol response to ACTH stimulation in healthy volunteers and patients with altered CBG concentrations; (2) to evaluate the performance of a lower reference limit (LRL) determined in healthy volunteers in patients with suspected hypoadrenalism (SH-patients).
A 250 µg ACTH stimulation test was undertaken in 139 healthy volunteers, 24 women taking an estradiol-containing oral contraceptive pill (OCP-females), 10 patients with low serum protein concentration (LP-patients), and 30 SH-patients. Salivary cortisol was measured by liquid chromatography-tandem mass spectrometry. Mean and LRL of the 30-minute salivary cortisol response (mean-1.96 standard deviation) were derived from log-transformed concentrations. The LRL was applied as a diagnostic cut-off in SH-patients, with comparison to the serum response.
Mean CBG concentrations (range) were 58 (42-81) mg/L, 64 (43-95) mg/L, 41 (28-60) mg/L, and 116 (84-159) mg/L in males, females, LP-patients, and OCP-females, respectively. The mean 30-minute salivary cortisol concentration was 19.3 (2.5th-97.5th percentile 10.3-36.2) nmol/L in healthy volunteers. Corresponding values were not different in OCP-females [19.7 (9.5-41.2) nmol/L; P = .59] or LP-patients [19.0 (7.7-46.9) nmol/L; P = .97]. Overall diagnostic agreement between salivary and serum responses in SH-patients was 79%.
Salivary cortisol response to ACTH stimulation offers a reliable alternative to serum and may be especially useful in conditions of altered CBG concentration.
血清总皮质醇对促肾上腺皮质激素(ACTH)刺激试验的反应广泛用于评估肾上腺皮质功能,但会受到皮质醇结合球蛋白(CBG)浓度变化的影响。唾液皮质醇反映游离皮质醇浓度,可能是一种可靠的替代方法。
(1)确定健康志愿者和 CBG 浓度改变的患者对 ACTH 刺激的唾液皮质醇反应;(2)评估在疑似肾上腺功能减退症(SH-患者)中使用在健康志愿者中确定的较低参考限(LRL)的性能。
对 139 名健康志愿者、24 名服用含有雌二醇的口服避孕药(OCP-女性)、10 名低血清蛋白浓度(LP-患者)和 30 名 SH-患者进行了 250μg ACTH 刺激试验。唾液皮质醇通过液相色谱-串联质谱法测量。30 分钟唾液皮质醇反应的平均值和 LRL(平均值-1.96 标准差)是从对数转换后的浓度得出的。在 SH-患者中,将 LRL 用作诊断截止值,并与血清反应进行比较。
男性、女性、LP-患者和 OCP-女性的平均 CBG 浓度(范围)分别为 58(42-81)mg/L、64(43-95)mg/L、41(28-60)mg/L 和 116(84-159)mg/L。健康志愿者 30 分钟唾液皮质醇浓度的平均值为 19.3(2.5th-97.5th 百分位数 10.3-36.2)nmol/L。OCP-女性[19.7(9.5-41.2)nmol/L;P=.59]或 LP-患者[19.0(7.7-46.9)nmol/L;P=.97]的相应值没有差异。SH-患者唾液和血清反应之间的总体诊断一致性为 79%。
ACTH 刺激后的唾液皮质醇反应是血清的可靠替代方法,在 CBG 浓度改变的情况下可能特别有用。